Viewing Study NCT03105102


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-03-05 @ 6:29 PM
Study NCT ID: NCT03105102
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-14
First Post: 2017-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module